// App-Quantinova.ai

: SGLT2 Inhibition Suppresses Glucagon Response to Hypoglycemia in Male but Not Female Rats with Streptozotocin-Induced Type 1 Diabetes

Researchers

Presenter

  • CAYLEE A. GREENBERG

Principal Investigators

  • ERIN R. MANDEL

  • AOIBHE M. PASIEKA

  • MAHSA JAHANGIRIESMAILI

  • JULIE TREMBLAY

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • Streptozotocin

  • BI-10773

  • Intranasal glucagon

Outcome

  • N/A


Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A